Co-Existence of Hereditary Pyrimidine 5’-Nucleotidase Deficiency and Heterozygous α-Thalassemia: A Case Presentation

Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 4

Abstract

To the Editor, Pyrimidine 5’-nucleotidase (P5N) is an intra-erythrocytic isoenzyme that catalyzes the dephosphorylation of pyrimidine ribonucleotides, which are the product of DNA catabolism. A reduction in P5N reactivity leads to accumulation of pyrimidine products in erythrocytes, which increases its life span, resulting in hemolytic anemia and intense basophilic stippling [1].

Authors and Affiliations

A. Agapidou, S. Theodoridou, K. Tegos, E. Mandala, O. Karakasidou, B. Aletra, M. Alemayehou

Keywords

Related Articles

Long-term Dental Anomalies after Pediatric Cancer Treatment in Children

Objective: The aim of this study is to determine the frequency of dental anomalies (DAs) (microdontia, hypodontia, hyperdontia, enamel defect, root malformation) in pediatric cancer patients at the ages <5 years and betw...

Download PDF file
  • EP ID EP121991
  • DOI 10.5505/tjh.2012.48642
  • Views 85
  • Downloads 0

How To Cite

A. Agapidou, S. Theodoridou, K. Tegos, E. Mandala, O. Karakasidou, B. Aletra, M. Alemayehou (2012). Co-Existence of Hereditary Pyrimidine 5’-Nucleotidase Deficiency and Heterozygous α-Thalassemia: A Case Presentation. Turkish Journal of Hematology, 29(4), 433-435. https://europub.co.uk/articles/-A-121991